Insider · CIK 0001984204
Tammy Furlong
cfoofficer
Files at ELEV (Elevation Oncology, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | UTender of shares Common Stock | -37,957 | $0.36 | $14k | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -79,327 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -79,327 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -52,500 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -28,800 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -53,433 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -225,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| Jul 23, 2025 | ELEV Elevation Oncology, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -275,000 | $0.00 | $0 | 0 | Jul 24, 2025 |
| May 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Common Stock | +2,643 | - | - | 10,859 | May 19, 2025 |
| May 15, 2025 | ELEV Elevation Oncology, Inc. | FTax withholding Common Stock | -784 | $0.30 | $235 | 10,075 | May 19, 2025 |
| May 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -2,343 | $0.00 | $0 | 25,782 | May 19, 2025 |
| May 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -300 | $0.00 | $0 | 2,100 | May 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Common Stock | +9,375 | - | - | 10,785 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | FTax withholding Common Stock | -2,780 | $0.67 | $1,867 | 8,005 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Common Stock | +300 | - | - | 8,305 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | FTax withholding Common Stock | -89 | $0.67 | $60 | 8,216 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -9,375 | $0.00 | $0 | 28,125 | Feb 19, 2025 |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -300 | $0.00 | $0 | 2,400 | Feb 19, 2025 |
| Nov 15, 2024 | ELEV Elevation Oncology, Inc. | MOption exercise Common Stock | +300 | - | - | 1,508 | Nov 19, 2024 |
| Nov 15, 2024 | ELEV Elevation Oncology, Inc. | FTax withholding Common Stock | -98 | $0.53 | $52 | 1,410 | Nov 19, 2024 |
| Nov 15, 2024 | ELEV Elevation Oncology, Inc. | MOption exercise Restricted Stock Unitderivative | -300 | $0.00 | $0 | 2,700 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.